Drug Transporters At Brain Barriers

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4614-4711-5_2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug Transport across the Blood–Brain Barrier

  2012cited by this paper
• Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP

  2012cited by this paper
• Engaging neuroscience to advance translational research in brain barrier biology

  2011cited by this paper
• Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro.

  2011cited by this paper
• Regulation of P‐glycoprotein by human immunodeficiency virus‐1 in primary cultures of human fetal astrocytes

  2011cited by this paper
• Role of Astrocytes in Brain Function and Disease

  2011cited by this paper
• In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.

  2011cited by this paper
• Active efflux across the blood-brain barrier: Role of the solute carrier family

  2011cited by this paper
• Distribution of Glycylsarcosine and Cefadroxil among Cerebrospinal Fluid, Choroid Plexus, and Brain Parenchyma after Intracerebroventricular Injection is Markedly Different between Wild-Type and Pept2 Null Mice

  2011cited by this paper
• Regulation of P‐glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells

  2011cited by this paper
• ABCC6 as a target in pseudoxanthoma elasticum.

  2011cited by this paper
• Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat

  2011cited by this paper
• The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain

  2011cited by this paper
• Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.

  2011cited by this paper
• Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms.

  2011cited by this paper
• Intact Lipid Rafts Regulate HIV-1 Tat Protein-Induced Activation of the Rho Signaling and Upregulation of P-Glycoprotein in Brain Endothelial Cells

  2010cited by this paper
• Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Functional Characterization of Mouse Organic Anion Transporting Peptide 1a4 in the Uptake and Efflux of Drugs Across the Blood-Brain Barrier

  2010cited by this paper
• Influence of blood-brain barrier efflux pumps on the distribution of vincristine in brain and brain tumors.

  2010cited by this paper
• The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters.

  2010cited by this paper
• Parkinson's disease: Exit toxins, enter genetics

  2010cited by this paper
• ABCG2 reduces ROS‐mediated toxicity and inflammation: a potential role in Alzheimer’s disease

  2010cited by this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cited by this paper
• Neurologic disease burden in treated HIV/AIDS predicts survival

  2010cited by this paper
• Potential future neuroprotective therapies for neurodegenerative disorders and stroke.

  2010cited by this paper
• Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier

  2010cited by this paper
• Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux

  2010cited by this paper
• Estrogen Receptor β Signaling through Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/Akt/Glycogen Synthase Kinase 3 Down-Regulates Blood-Brain Barrier Breast Cancer Resistance Protein

  2010cited by this paper
• Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging

  2010cited by this paper
• Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines.

  2010cited by this paper
• HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

  2010cited by this paper
• Regulation of Multidrug Resistance Protein 1 by Tumor Necrosis Factor α in Cultured Glial Cells: Involvement of Nuclear Factor-κB and c-Jun N-Terminal Kinase Signaling Pathways

  2010cited by this paper
• Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy.

  2010cited by this paper
• 17-β-Estradiol: A Powerful Modulator of Blood–Brain Barrier BCRP Activity

  2010cited by this paper
• MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• High Impact of Oatp1a/1b Transporters on In Vivo Disposition of the Hydrophobic Anticancer Drug Paclitaxel

  2010cited by this paper
• Coexistence of passive and carrier-mediated processes in drug transport

  2010cited by this paper
• Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

  2010cited by this paper
• Expression and functional activity of nucleoside transporters in human choroid plexus

  2010cited by this paper
• A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy

  2010cited by this paper
• pH Dependence of Organic Anion-Transporting Polypeptide 2B1 in Caco-2 Cells: Potential Role in Antiretroviral Drug Oral Bioavailability and Drug–Drug Interactions

  2010cited by this paper
• Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls

  2009cited by this paper
• Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line

  2009cited by this paper
• Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters.

  2009cited by this paper
• Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.

  2009cited by this paper
• Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells.

  2009cited by this paper
• Pregnane X Receptor (PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between Pig and Human PXR

  2009cited by this paper
• Oligodendrocytes

  2009cited by this paper
• In vivo, in vitro and in silico methods for small molecule transfer across the BBB.

  2009cited by this paper
• Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.

  2009cited by this paper
• Parkinson's disease: The syndrome, the pathogenesis and pathophysiology

  2009cited by this paper
• Analysis and update of the human solute carrier (SLC) gene superfamily

  2009cited by this paper
• P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β

  2009cited by this paper
• Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.

  2009cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009cited by this paper
• Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice

  2009cited by this paper
• Drug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood-testis barrier.

  2009cited by this paper
• Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide

  2009cited by this paper
• ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides

  2009cited by this paper
• Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood–Brain Barrier

  2009cited by this paper
• Association of a polymorphism in the ABCB1 gene with Parkinson's disease.

  2009cited by this paper
• Regulation of major efflux transporters under inflammatory conditions at the blood‐brain barrier in vitro

  2009cited by this paper
• Pericyte Signaling in the Neurovascular Unit

  2009cited by this paper
• Several major antiepileptic drugs are substrates for human P-glycoprotein.

  2008cited by this paper
• Regulation of ABC membrane transporters in glial cells: Relevance to the pharmacotherapy of brain HIV‐1 infection

  2008cited by this paper
• The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies

  2008cited by this paper
• Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients

  2008cited by this paper
• HIV‐1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein‐1 (Mrp1) in glial cells

  2008cited by this paper
• Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA

  2008cited by this paper
• Peptide transporters and their roles in physiological processes and drug disposition

  2008cited by this paper
• Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.

  2008cited by this paper
• SLC28 genes and concentrative nucleoside transporter (CNT) proteins

  2008cited by this paper
• Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics

  2008cited by this paper
• Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

  2008cited by this paper
• Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins

  2008cited by this paper
• nteractions between antiparkinsonian drugs and ABCB 1 / P-glycoprotein t the blood – brain barrier in a rat brain endothelial cell model

  2008cited by this paper
• Comparison of ABC Transporter Modulation by Atazanavir in Lymphocytes and Human Brain Endothelial Cells: ABC Transporters Are Involved in the Atazanavir-Limited Passage across an in Vitro Human Model of the Blood–Brain Barrier

  2008cited by this paper
• ABC multidrug transporters: structure, function and role in chemoresistance.

  2008cited by this paper
• Pericytes: pluripotent cells of the blood brain barrier.

  2008cited by this paper
• MRP8/ABCC11 directly confers resistance to 5-fluorouracil

  2007cited by this paper
• Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications

  2007cited by this paper
• Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter.

  2007cited by this paper
• Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain Barrier

  2007cited by this paper
• Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage.

  2007cited by this paper
• Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice

  2007cited by this paper
• MDR1‐P‐Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s Amyloid‐β Peptides—Implications for the Mechanisms of Aβ Clearance at the Blood–Brain Barrier

  2007cited by this paper
• P-glycoprotein-Mediated Active Efflux of the Anti-HIV1 Nucleoside Abacavir Limits Cellular Accumulation and Brain Distribution

  2007cited by this paper
• PPARα Agonists Positively and Negatively Regulate the Expression of Several Nutrient/Drug Transporters in Mouse Small Intestine

  2007cited by this paper
• Structure and mechanism of ABC transporter proteins.

  2007cited by this paper
• Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain.

  2007cited by this paper
• Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles

  2007cited by this paper
• Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood–brain barrier

  2007cited by this paper
• Expression of the ATP-binding Cassette Membrane Transporter, ABCG2, in Human and Rodent Brain Microvessel Endothelial and Glial Cell Culture Systems

  2007cited by this paper
• In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain

  2006cited by this paper
• Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System

  2006cited by this paper
• Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes

  2006cited by this paper
• Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)

  2006cited by this paper
• Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system.

  2006cited by this paper
• PEPT2-mediated transport of 5-aminolevulinic acid and carnosine in astrocytes.

  2006cited by this paper

• Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

  2021cites this paper
• Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics.

  2018cites this paper
• Signaling pathways regulating blood-tissue barriers - Lesson from the testis.

  2018cites this paper
• Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors

  2018cites this paper
• Innate Immunity Cells and the Neurovascular Unit

  2018cites this paper
• Drug Transporters as Therapeutic Targets: Computational Models, Challenges, and Future Perspective

  2018cites this paper
• Platinum-induced neurotoxicity and preventive strategies: past, present, and future.

  2015cites this paper
• (125)I-Labelled 2-Iodoestrone-3-sulfate: synthesis, characterization and OATP mediated transport studies in hormone dependent and independent breast cancer cells.

  2015cites this paper
• Biochemistry of Sertoli cell/germ cell junctions, germ cell transport, and spermiation in the seminiferous epithelium

  2015cites this paper
• OATP mediated transport studies in hormone dependent and independent breast cancer cells

  2015cites this paper
• Role of nuclear factor-erythroid 2-related factor 2 (Nrf2) in the transcriptional regulation of brain ABC transporters during acute acetaminophen (APAP) intoxication in mice.

  2015cites this paper
• Drug Transporters in the Central Nervous System

  2015cites this paper
• Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.

  2014cites this paper
• Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.

  2014cites this paper
• Regulation of P-glycoprotein by Nuclear Receptors at the Blood-brain Barrier: Relevance to Human Immunodeficiency Virus-1 Pharmacotherapy

  2014cites this paper
• Focal adhesion kinase is a regulator of F-actin dynamics

  2013cites this paper
• Role of nuclear receptors in the regulation of drug transporters in the brain.

  2013cites this paper
• Breast cancer resistance protein (Bcrp) and the testis--an unexpected turn of events.

  2013cites this paper